270 related articles for article (PubMed ID: 29580612)
1. Drug evaluation in children 10years after the European pediatric regulation current challenges and perspectives.
Élie V; Leroux S; Kaguelidou F; Jacqz-Aigrain E
Therapie; 2018 Apr; 73(2):113-117. PubMed ID: 29580612
[TBL] [Abstract][Full Text] [Related]
2. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
[TBL] [Abstract][Full Text] [Related]
3. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
4. Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years.
Ceci A; Felisi M; Baiardi P; Bonifazi F; Catapano M; Giaquinto C; Nicolosi A; Sturkenboom M; Neubert A; Wong I
Eur J Clin Pharmacol; 2006 Nov; 62(11):947-52. PubMed ID: 17021892
[TBL] [Abstract][Full Text] [Related]
5. Drug development: EU paediatric legislation, the European Medicines Agency and its Paediatric Committee--adolescents' melanoma as a paradigm.
Rose K; Senn S
Pharm Stat; 2014; 13(4):211-3. PubMed ID: 24903307
[TBL] [Abstract][Full Text] [Related]
6. More medicines for children: impact of the EU paediatric regulation.
Nordenmalm S; Tomasi P; Pallidis C
Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
[TBL] [Abstract][Full Text] [Related]
7. The EU paediatric regulation: still a large discrepancy between therapeutic needs and approved paediatric investigation plans.
Wimmer S; Rascher W; McCarthy S; Neubert A
Paediatr Drugs; 2014 Oct; 16(5):397-406. PubMed ID: 25056717
[TBL] [Abstract][Full Text] [Related]
8. Moving toward a paradigm shift in the regulatory requirements for pediatric medicines.
Chin WW; Joos A
Eur J Pediatr; 2016 Dec; 175(12):1881-1891. PubMed ID: 27646479
[TBL] [Abstract][Full Text] [Related]
9. [Pediatric drug development: ICH harmonized tripartite guideline E11 within the United States of America, the European Union, and Japan].
Pflieger M; Bertram D
Arch Pediatr; 2014 Oct; 21(10):1129-38. PubMed ID: 25175054
[TBL] [Abstract][Full Text] [Related]
10. NIHR Medicines for Children Research Network: improving children's health through clinical research.
Rose AC; Van't Hoff W; Beresford MW; Tansey SP
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):581-7. PubMed ID: 24070097
[TBL] [Abstract][Full Text] [Related]
11. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
Mentzer D
Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
[TBL] [Abstract][Full Text] [Related]
12. Who are the PDCO?
Dempsey EM; Connolly K
Eur J Pediatr; 2014 Feb; 173(2):233-5. PubMed ID: 23925423
[TBL] [Abstract][Full Text] [Related]
13. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
14. Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.
Tomić S; Sucić AF; Martinac AI
Regul Toxicol Pharmacol; 2010; 57(2-3):325-32. PubMed ID: 20385190
[TBL] [Abstract][Full Text] [Related]
15. Pediatric drug regulation: International perspectives.
Baum VC; Bax R; Heon D; Yang Z; Sakiyama M
Paediatr Anaesth; 2019 Jun; 29(6):572-582. PubMed ID: 30924233
[TBL] [Abstract][Full Text] [Related]
16. Enabling Development of Paediatric Medicines in Europe: 10 Years of the EU Paediatric Regulation.
Tomasi PA; Egger GF; Pallidis C; Saint-Raymond A
Paediatr Drugs; 2017 Dec; 19(6):505-513. PubMed ID: 28900869
[TBL] [Abstract][Full Text] [Related]
17. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
18. Regulatory policies on medicines for psychiatric disorders: is Europe on target?
Barbui C; Garattini S
Br J Psychiatry; 2007 Feb; 190():91-3. PubMed ID: 17267922
[TBL] [Abstract][Full Text] [Related]
19. The Task-force in Europe for Drug Development for the Young (TEDDY) Network of Excellence.
Ceci A; Giaquinto C; Aboulker JP; Baiardi P; Bonifazi F; Della Pasqua O; Nicolosi A; Taruscio D; Sturkenboom M; Wong I
Paediatr Drugs; 2009; 11(1):18-21. PubMed ID: 19127946
[TBL] [Abstract][Full Text] [Related]
20. Improvement of Pediatric Drug Development: Regulatory and Practical Frameworks.
Tsukamoto K; Carroll KA; Onishi T; Matsumaru N; Brasseur D; Nakamura H
Clin Ther; 2016 Mar; 38(3):574-81. PubMed ID: 26869192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]